Posters
« Back
CellTiter-Glo® 2.0: A Novel Luminescent Cell Viability Assay with Greatly Enhanced Storage Stability
EP23506
Poster Title: CellTiter-Glo® 2.0: A Novel Luminescent Cell Viability Assay with Greatly Enhanced Storage Stability
Submitted on 09 Oct 2015
Author(s): Michael P. Valley, James Unch, Poncho L. Meisenheimer, James J. Cali, and Dan F. Lazar
Affiliations: Promega Corporation
Poster Views: 2,321
View poster »


Poster Information
Abstract: Here we report on the attributes of a novel ATP detection reagent for cell viability with all of the assay performance of the previous CellTiter-Glo® Reagent, but now with markedly enhanced stability as a single component in a liquid format. These new features provide for much greater ease-of-use in that storage of the reagent at 4°C eliminates the requirement for reagent thawing and minimizes temperature equilibration time. The enhanced stability also means that reagent performance is maintained at room temperature during extended assay operations, and any unused reagent can be retained for future use by simply returning it to 4°C storage rather than having to freeze or discard it.Summary: Here we report on the attributes of a novel ATP detection reagent for cell viability with all of the assay performance of the previous CellTiter-Glo® Reagent, but now with markedly enhanced stability as a single component in a liquid format. These new features provide for much greater ease-of-use in that storage of the reagent at 4°C eliminates the requirement for reagent thawing and minimizes temperature equilibration time. References: Michael P. Valley1, James Unch2, Poncho L. Meisenheimer2, James J. Cali1, and Dan F. Lazar1
1Promega Corporation, 2800 Woods Hollow Road, Madison, WI 53711-5399
2Promega Biosciences, 277 Granada Dr., San Luis Obispo, CA 93401
Report abuse »
Questions
Ask the author a question about this poster.
Ask a Question »

Creative Commons

Related Posters


low-volume workflows improve the quality of drug discovery: two case studies
Margaret Kenney#, Archi Joardar#, Vasudeo Badarinarayana#, Joby Jenkins*

A CASE SERIES ON OCULAR MANIFESTATIONS IN STEVEN JOHNSON SYNDROME AND THEIR VARIED PRESENTATION-REVIEW OF LITERATURE
1. Dr Nagalakshmi Narayana-Swamy, 2. Dr Alhaj Farhath Tasneem

ExpiSf™ Expression system: A Chemically Defined Baculovirus-Based System for Enhanced Protein and Virus Production in Sf9 Cells
Kenneth Thompson, Maya Yovcheva, Sara Barnes, Melissa Cross, Katy Irvin, Natasha Lucki, Henry Chiou, and Jonathan Zmuda

Dissecting the genomic profile of persistently infecting oncolytic Newcastle disease virus (NDVpi) from cancer RNA-Seq data
Ahmad U1, Chan SC2, Chau DM1, Chia SL5, Abdullah S1,3, Yusoff K5 & Veerakumarasivam A1,4*

FCP: Principles in Comparison
Cho, Rai, Chong, Mey, Hazirah